about
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Read More
15.56
-0.26
(-1.64%)
152.9K
XNAS Volume
XNAS 12 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Amarin Corp (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..